| Update of safety review-follow-up to the January 25, 2008 early communication about an ongoing data review for ezetimibe/simvastatin (marketed as Vytorin), ezetimibe (marketed as Zetia), and simvastatin (marketed as Zocor). January 8, 2009 |
| Fonte: www.fda.gov |
Update
of Safety Review January 8, 2009 |